Stem cell therapies: a new era in the treatment of multiple sclerosis
- PMID: 38784908
- PMCID: PMC11111935
- DOI: 10.3389/fneur.2024.1389697
Stem cell therapies: a new era in the treatment of multiple sclerosis
Abstract
Multiple Sclerosis (MS) is an immune-mediated condition that persistently harms the central nervous system. While existing treatments can slow its course, a cure remains elusive. Stem cell therapy has gained attention as a promising approach, offering new perspectives with its regenerative and immunomodulatory properties. This article reviews the application of stem cells in MS, encompassing various stem cell types, therapeutic potential mechanisms, preclinical explorations, clinical research advancements, safety profiles of clinical applications, as well as limitations and challenges, aiming to provide new insights into the treatment research for MS.
Keywords: induced pluripotent stem cells; multiple sclerosis; neural stem cells; stem cell therapy; stem cell transplantation.
Copyright © 2024 Wu, Lu, Lan, Zhang, Xu, Kang, Peng and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Promises and Limitations of Neural Stem Cell Therapies for Progressive Multiple Sclerosis.Trends Mol Med. 2020 Oct;26(10):898-912. doi: 10.1016/j.molmed.2020.04.005. Epub 2020 May 21. Trends Mol Med. 2020. PMID: 32448751 Review.
-
Stem Cell Therapy for Multiple Sclerosis.Adv Exp Med Biol. 2019;1084:145-174. doi: 10.1007/5584_2018_247. Adv Exp Med Biol. 2019. PMID: 30039439 Review.
-
Induced Stem Cells as a Novel Multiple Sclerosis Therapy.Curr Stem Cell Res Ther. 2016;11(4):313-20. doi: 10.2174/1574888x10666150302110013. Curr Stem Cell Res Ther. 2016. PMID: 25732737 Free PMC article. Review.
-
Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.Sci China Life Sci. 2016 Sep;59(9):950-7. doi: 10.1007/s11427-016-0114-9. Epub 2016 May 27. Sci China Life Sci. 2016. PMID: 27233903
-
Advances in human stem cell therapies: pre-clinical studies and the outlook for central nervous system regeneration.Neural Regen Res. 2021 Apr;16(4):614-617. doi: 10.4103/1673-5374.295287. Neural Regen Res. 2021. PMID: 33063709 Free PMC article.
Cited by
-
Primary Progressive Multiple Sclerosis: New Therapeutic Approaches.Neuropsychopharmacol Rep. 2025 Sep;45(3):e70039. doi: 10.1002/npr2.70039. Neuropsychopharmacol Rep. 2025. PMID: 40653594 Free PMC article. Review.
-
Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives.Eur J Med Res. 2024 Jul 25;29(1):386. doi: 10.1186/s40001-024-01987-1. Eur J Med Res. 2024. PMID: 39054501 Free PMC article. Review.
-
Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders.Int J Mol Sci. 2024 Dec 19;25(24):13614. doi: 10.3390/ijms252413614. Int J Mol Sci. 2024. PMID: 39769374 Free PMC article. Review.
-
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms.Expert Rev Neurother. 2025 Jul;25(7):791-817. doi: 10.1080/14737175.2025.2510405. Epub 2025 Jun 3. Expert Rev Neurother. 2025. PMID: 40440559 Free PMC article. Review.
References
-
- Ahmadvand Koohsari S, Absalan A, Azadi D. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles attenuate experimental autoimmune encephalomyelitis via regulating pro and anti-inflammatory cytokines. Sci Rep. (2021) 11:11658. doi: 10.1038/s41598-021-91291-3, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources